Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-06-28 Purchase | 2021-06-30 6:09 pm | Monte Rosa Therapeutics Inc. | GLUE | Yang Rick 10% Owner | 1,050,000 | $19 | $19,950,000 | 7,692,298 (Indirect) | View |
| 2021-06-28 Purchase | 2021-06-30 6:08 pm | Monte Rosa Therapeutics Inc. | GLUE | Walker Paul Edward 10% Owner | 1,050,000 | $19 | $19,950,000 | 7,692,298 (Indirect) | View |
| 2021-06-28 Purchase | 2021-06-30 6:08 pm | Monte Rosa Therapeutics Inc. | GLUE | Sonsini Peter W. 10% Owner | 1,050,000 | $19 | $19,950,000 | 7,692,298 (Indirect) | View |
| 2021-06-28 Purchase | 2021-06-30 6:07 pm | Monte Rosa Therapeutics Inc. | GLUE | SANDELL SCOTT D 10% Owner | 1,050,000 | $19 | $19,950,000 | 7,692,298 (Indirect) | View |
| 2021-06-28 Purchase | 2021-06-30 6:06 pm | Monte Rosa Therapeutics Inc. | GLUE | Mathers Edward T 10% Owner | 1,050,000 | $19 | $19,950,000 | 7,692,298 (Indirect) | View |
| 2021-06-28 Purchase | 2021-06-30 6:06 pm | Monte Rosa Therapeutics Inc. | GLUE | MAKOWER JOSHUA 10% Owner | 1,050,000 | $19 | $19,950,000 | 7,692,298 (Indirect) | View |
| 2021-06-28 Purchase | 2021-06-30 6:05 pm | Monte Rosa Therapeutics Inc. | GLUE | Makhzoumi Mohamad 10% Owner | 1,050,000 | $19 | $19,950,000 | 7,692,298 (Indirect) | View |
| 2021-06-28 Purchase | 2021-06-30 6:04 pm | Monte Rosa Therapeutics Inc. | GLUE | Landsman Liza 10% Owner | 1,050,000 | $19 | $19,950,000 | 7,692,298 (Indirect) | View |
| 2021-06-28 Purchase | 2021-06-30 6:02 pm | Monte Rosa Therapeutics Inc. | GLUE | Florence Anthony A. Jr. 10% Owner | 1,050,000 | $19 | $19,950,000 | 7,692,298 (Indirect) | View |
| 2021-06-28 Purchase | 2021-06-30 6:02 pm | Monte Rosa Therapeutics Inc. | GLUE | Chang Carmen 10% Owner | 1,050,000 | $19 | $19,950,000 | 7,692,298 (Indirect) | View |
| 2021-06-28 Purchase | 2021-06-30 6:01 pm | Monte Rosa Therapeutics Inc. | GLUE | Behbahani Ali Director 10% Owner | 1,050,000 | $19 | $19,950,000 | 7,692,298 (Indirect) | View |
| 2021-06-28 Purchase | 2021-06-30 6:00 pm | Monte Rosa Therapeutics Inc. | GLUE | BASKETT FOREST 10% Owner | 1,050,000 | $19 | $19,950,000 | 7,692,298 (Indirect) | View |
| 2021-06-28 Purchase | 2021-06-30 5:59 pm | Monte Rosa Therapeutics Inc. | GLUE | New Enterprise Associates 17 L.P. NEA Partners 17 L.P. NEA 17 GP LLC 10% Owner | 1,050,000 | $19 | $19,950,000 | 7,692,298 (Direct) | View |
| 2021-06-28 Purchase | 2021-06-30 5:05 pm | Monte Rosa Therapeutics Inc. | GLUE | Bolzon Bradley J PhD Director 10% Owner | 157,895 | $19 | $3,000,005 | 2,097,938 (Indirect) | View |
| 2021-06-28 Purchase | 2021-06-30 5:00 pm | Monte Rosa Therapeutics Inc. | GLUE | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 157,895 | $19 | $3,000,005 | 8,897,053 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-01-03 Option Award | 2023-01-04 4:31 pm | N/A 2033-01-02 | Monte Rosa Therapeutics Inc. | GLUE | Wallace Owen B. Chief Scientific Officer | 135,000 | $0 | 135,000 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-04 4:31 pm | N/A 2033-01-02 | Monte Rosa Therapeutics Inc. | GLUE | Warmuth Markus President & CEO | 472,000 | $0 | 472,000 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-04 4:31 pm | N/A 2033-01-02 | Monte Rosa Therapeutics Inc. | GLUE | Nickson Philip General Counsel | 123,650 | $0 | 123,650 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-04 4:31 pm | N/A 2033-01-02 | Monte Rosa Therapeutics Inc. | GLUE | Townson Sharon Chief Technology Officer | 78,550 | $0 | 78,550 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-04 4:30 pm | N/A 2033-01-02 | Monte Rosa Therapeutics Inc. | GLUE | Jones Jullian G Chief Business Officer | 77,450 | $0 | 77,450 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-04 4:30 pm | N/A 2033-01-02 | Monte Rosa Therapeutics Inc. | GLUE | Castle John C. Chief Data Scientist | 78,500 | $0 | 78,500 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-04 4:30 pm | N/A 2033-01-02 | Monte Rosa Therapeutics Inc. | GLUE | Tamboli Ajim Chief Financial Officer | 129,850 | $0 | 129,850 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-04 4:30 pm | N/A 2033-01-02 | Monte Rosa Therapeutics Inc. | GLUE | Janku Filip Chief Medical Officer | 135,000 | $0 | 135,000 (Direct) | View |
| 2022-12-15 Option Award | 2022-12-19 4:42 pm | N/A 2032-10-02 | Monte Rosa Therapeutics Inc. | GLUE | Janku Filip Chief Medical Officer | 36,000 | $0 | 36,000 (Direct) | View |
| 2022-10-31 Option Award | 2022-11-01 4:30 pm | N/A 2032-10-02 | Monte Rosa Therapeutics Inc. | GLUE | Janku Filip Chief Medical Officer | 36,000 | $0 | 36,000 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-16 5:29 pm | N/A 2032-06-14 | Monte Rosa Therapeutics Inc. | GLUE | Behbahani Ali Director 10% Owner | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-16 4:32 pm | N/A 2032-06-14 | Monte Rosa Therapeutics Inc. | GLUE | Siu Christine Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-16 4:31 pm | N/A 2032-06-14 | Monte Rosa Therapeutics Inc. | GLUE | SCHIFF ANDREW N Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-16 4:30 pm | N/A 2032-06-14 | Monte Rosa Therapeutics Inc. | GLUE | Mayweg Alexander Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-16 4:30 pm | N/A 2032-06-14 | Monte Rosa Therapeutics Inc. | GLUE | Blackwell Kimberly Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-02 6:49 pm | N/A 2032-02-29 | Monte Rosa Therapeutics Inc. | GLUE | Jones Jullian G Chief Business Officer | 73,300 | $0 | 73,300 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-02 6:47 pm | N/A 2032-02-29 | Monte Rosa Therapeutics Inc. | GLUE | Tamboli Ajim Chief Financial Officer | 111,700 | $0 | 111,700 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-02 6:46 pm | N/A 2032-02-29 | Monte Rosa Therapeutics Inc. | GLUE | Janku Filip Chief Medical Officer | 86,500 | $0 | 86,500 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-02 6:46 pm | N/A 2032-02-29 | Monte Rosa Therapeutics Inc. | GLUE | Townson Sharon Chief Technology Officer | 70,000 | $0 | 70,000 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-02 6:43 pm | N/A 2032-02-29 | Monte Rosa Therapeutics Inc. | GLUE | Nickson Philip General Counsel | 70,600 | $0 | 70,600 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-02 6:42 pm | N/A 2032-02-29 | Monte Rosa Therapeutics Inc. | GLUE | Castle John C. Chief Data Scientist | 53,700 | $0 | 53,700 (Direct) | View |
| 2022-03-01 Ownership | 2022-03-02 6:39 pm | N/A 2031-05-16 | Monte Rosa Therapeutics Inc. | GLUE | Nickson Philip General Counsel | 0 | $0 | 116,120 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-02 6:32 pm | N/A 2032-02-29 | Monte Rosa Therapeutics Inc. | GLUE | Wallace Owen B. Chief Scientific Officer | 117,450 | $0 | 117,450 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-02 6:26 pm | N/A 2032-02-29 | Monte Rosa Therapeutics Inc. | GLUE | Warmuth Markus President & CEO | 315,600 | $0 | 315,600 (Direct) | View |
| 2021-12-01 Ownership | 2021-12-02 6:12 pm | N/A 2030-08-31 | Monte Rosa Therapeutics Inc. | GLUE | Jones Julian G Chief Business Officer | 0 | $0 | 251,594 (Direct) | View |
| 2021-06-28 Conversion | 2021-06-30 6:09 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Yang Rick 10% Owner | 30,092,935 | $0 | 7,692,298 (Indirect) | View |
| 2021-06-28 Conversion | 2021-06-30 6:08 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Walker Paul Edward 10% Owner | 30,092,935 | $0 | 7,692,298 (Indirect) | View |
| 2021-06-28 Conversion | 2021-06-30 6:08 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Sonsini Peter W. 10% Owner | 30,092,935 | $0 | 7,692,298 (Indirect) | View |
| 2021-06-28 Conversion | 2021-06-30 6:07 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | SANDELL SCOTT D 10% Owner | 30,092,935 | $0 | 7,692,298 (Indirect) | View |
| 2021-06-28 Conversion | 2021-06-30 6:06 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Mathers Edward T 10% Owner | 30,092,935 | $0 | 7,692,298 (Indirect) | View |
| 2021-06-28 Conversion | 2021-06-30 6:06 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | MAKOWER JOSHUA 10% Owner | 30,092,935 | $0 | 7,692,298 (Indirect) | View |
| 2021-06-28 Conversion | 2021-06-30 6:05 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Makhzoumi Mohamad 10% Owner | 30,092,935 | $0 | 7,692,298 (Indirect) | View |
| 2021-06-28 Conversion | 2021-06-30 6:04 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Landsman Liza 10% Owner | 30,092,935 | $0 | 7,692,298 (Indirect) | View |
| 2021-06-28 Conversion | 2021-06-30 6:02 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Florence Anthony A. Jr. 10% Owner | 30,092,935 | $0 | 7,692,298 (Indirect) | View |
| 2021-06-28 Conversion | 2021-06-30 6:02 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Chang Carmen 10% Owner | 30,092,935 | $0 | 7,692,298 (Indirect) | View |
| 2021-06-28 Conversion | 2021-06-30 6:01 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Behbahani Ali Director 10% Owner | 30,092,935 | $0 | 7,692,298 (Indirect) | View |
| 2021-06-28 Conversion | 2021-06-30 6:00 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | BASKETT FOREST 10% Owner | 30,092,935 | $0 | 7,692,298 (Indirect) | View |
| 2021-06-28 Conversion | 2021-06-30 5:59 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | New Enterprise Associates 17 L.P. NEA Partners 17 L.P. NEA 17 GP LLC 10% Owner | 30,092,935 | $0 | 7,692,298 (Direct) | View |
| 2021-06-28 Conversion | 2021-06-30 5:05 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Bolzon Bradley J PhD Director 10% Owner | 38,309,520 | $0 | 2,097,938 (Indirect) | View |
| 2021-06-28 Conversion | 2021-06-30 5:00 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 38,309,520 | $0 | 8,897,053 (Direct) | View |